Shandong Keyuan Pharmaceutical Co. Ltd. A (301281) — Cash Flow Quality Index
Shandong Keyuan Pharmaceutical Co. Ltd. A (301281) has a Cash Flow Quality Index of -1.00x as of December 2024. Operating cash flow of CN¥-60.52 Million is below net income of CN¥60.45 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore how efficiently does Shandong Keyuan Pharmaceutical Co. Ltd. generate cash to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shandong Keyuan Pharmaceutical Co. Ltd. A Cash Flow Quality Index (2021–2024)
Historical Cash Flow Quality Index for Shandong Keyuan Pharmaceutical Co. Ltd. A across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Shandong Keyuan Pharmaceutical Co. Ltd. investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Shandong Keyuan Pharmaceutical Co. Ltd. A (2021–2024)
Year-by-year earnings quality comparison for Shandong Keyuan Pharmaceutical Co. Ltd. A. For live market cap and the full company financial profile, see Shandong Keyuan Pharmaceutical Co. Ltd. market cap and net worth.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -1.00x | CN¥-60.52 Million | CN¥60.45 Million | ▼ -308.3% |
| 2023 | 0.48x | CN¥37.03 Million | CN¥77.04 Million | ▼ -62.1% |
| 2022 | 1.27x | CN¥115.86 Million | CN¥91.28 Million | ▲ +90.7% |
| 2021 | 0.67x | CN¥52.02 Million | CN¥78.17 Million | — |